UROTEST GPH

K912244 · In Wha Pharmaceutical Co., Ltd. · JII · Nov 22, 1991 · Clinical Toxicology

Device Facts

Record IDK912244
Device NameUROTEST GPH
ApplicantIn Wha Pharmaceutical Co., Ltd.
Product CodeJII · Clinical Toxicology
Decision DateNov 22, 1991
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 862.3560
Device ClassClass 2

Regulatory Classification

Identification

A lithium test system is a device intended to measure lithium (from the drug lithium carbonate) in serum or plasma. Measurements of lithium are used to assure that the proper drug dosage is administered in the treatment of patients with mental disturbances, such as manic-depressive illness (bipolar disorder).

Innolitics

Panel 1

/
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...